Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Macromol Biosci ; 24(2): e2300277, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37658682

RESUMO

Ulcerative colitis is a chronic inflammatory bowel disease with a high recurrence rate. Natural phytochemical compounds are increasingly being considered as preventative and supportive treatments for this condition. However, the poor water solubility and stability of many of these compounds limit their effectiveness in vivo. To address this issue, fisetin (FT), a natural phytochemical with poor solubility, is stabilized using silk sericin (SS) to create a composite (SS/FT). The therapeutic potential of the SS/FT on ulcerative colitis is extensively investigated, and the results showed that it effectively alleviated the body weight loss and colon length shortening induced by dextran sulfate sodium. Notably, SS/FT downregulated the immune response, decreased colonic histopathological lesions, and reduced the cGAS/STING signal activation. This suggests that SS/FT may offer a promising therapy for treating ulcerative colitis.


Assuntos
Colite Ulcerativa , Flavonóis , Sericinas , Animais , Camundongos , Colite Ulcerativa/induzido quimicamente , Colite Ulcerativa/tratamento farmacológico , Colite Ulcerativa/patologia , Sericinas/efeitos adversos , Transdução de Sinais , NF-kappa B/metabolismo , Compostos Fitoquímicos/efeitos adversos , Sulfato de Dextrana , Modelos Animais de Doenças , Colo/patologia , Camundongos Endogâmicos C57BL
2.
Arch. bronconeumol. (Ed. impr.) ; 56(4): 225-233, abr. 2020. ilus, tab
Artigo em Inglês | IBECS | ID: ibc-194740

RESUMO

BACKGROUND: The aim of present study is to compare the effectiveness, side-effect potential of different doses of sericin pleurodesis. METHODS: Adult, male, 12-week-old, Wistar-albino rats (n = 52), were randomly-divided into four-groups, referred to A, B, C and D. Sericin was administrated at different doses through left thoracotomy, with 15mg sericin to Group-A, 30 mg to Group-B and 45 mg to Group-C. Group-D was assigned as control group. The rats were sacrificed 12 days later. Left-hemithorax, heart, liver and kidney were examined pathologically. RESULTS: No foreign body reaction in the parenchyma was observed in any of the rats, while emphysema was least common in Group-B (P < .05). Multi-layer mesothelium of both pleura was most common in Group-B, while fibrosis and fibrin organization within the visceral-pleura was more successful in all of sericin treated groups than in control group (P < .05), with neither Group-A, Group-B nor Group-C being superior to each other. In the examination of collagen fibers using Masson's trichrome, "dense collagen fibers" were found in all three sericin treated groups, and differences between Groups-A, -B, -C and the control group were significant (P < .05). The probability of observing pyknotic nucleus and balloon degeneration in liver increased with increasing sericin doses (P < .05). Glomerular degeneration in kidney and the findings of pericarditis were most common in Group-C (P < .05). CONCLUSION: The target should be to maximize efficacy while minimizing the likelihood of side-effects. The intrapleural administration of sericin 30 mg performs better due to multi-layer mesothelial reaction being higher and emphysema being lower in Group-B, to the fewer side-effects affecting the kidney and heart, and liver toxicity not being higher


INTRODUCCIÓN: El objetivo de este estudio es comparar la efectividad y los posibles efectos secundarios de diferentes dosis del agente pleurodésico sericina. MÉTODOS: Se utilizaron ratas macho albinas Wistar de 12 meses de edad (n = 52) que se dividieron aleatoriamente en 4 grupos, referidos como A, B, C y D. Se administró sericina a diferentes dosis a través de toracotomía izquierda: 15 mg al grupo A, 30 mg al grupo B y 45 mg al grupo C. El grupo D se utilizó como grupo control. Las ratas se sacrificaron 12 días más tarde. Se realizó examen patológico del hemitórax izquierdo, el hígado y el riñón. RESULTADOS: No se observaron reacciones a cuerpo extraño en el parénquima de ninguna de las ratas. El enfisema fue menos común en el grupo B (p < 0,05). El mesotelio multicapa en ambas pleuras fue más frecuente en el grupo B, mientras que la fibrosis y la organización de la fibrina en la pleura visceral tuvieron una mayor tasa de éxito en todos los grupos tratados con sericina que en el control (p < 0,05), sin ser mayor en ninguno de los grupos. Cuando se examinaron las fibras de colágeno mediante el tricrómico de Masson, se encontraron «fibras densas de colágeno» en los 3 grupos tratados con sericina, existiendo diferencias significativas entre los grupos A, B y C (p < 0,05). La probabilidad de observar núcleos picnóticos y degeneración «en globo» en el hígado se incrementó con el aumento de las dosis de sericina (p < 0,05). La degeneración glomerular en el riñón, y los hallazgos de pericarditis fueron más frecuentes en el grupo C (p < 0,05). CONCLUSIÓN: El objetivo debería ser maximizar la eficacia a la vez que se minimiza la probabilidad de efectos secundarios. La administración intrapleural de 30 mg de sericina resulta más eficaz debido a una mayor reacción mesotelial multicapa y a menor incidencia de enfisema (como se observa en el grupo B), así como a un menor número de efectos adversos que afectan al riñón y al corazón sin incremento concomitante de la toxicidad hepática


Assuntos
Animais , Masculino , Ratos , Pleurodese/métodos , Sericinas/administração & dosagem , Relação Dose-Resposta a Droga , Sericinas/efeitos adversos , Modelos Animais , Ratos Wistar
3.
Acta Biomater ; 74: 385-396, 2018 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-29783089

RESUMO

A variety of colloid stabilizers and cryoprotectants confer improved nanoparticle (NP) colloidal stability and redisperability. However, discounted tumor targetability, delivery efficacy and possible side effects limit the application in vascular delivery of NPs. Here we present water-soluble silk sericin (SS) not only as a material for the preparation of NPs, but also both a dispersion stabilizer and a cryoprotectant. In the absence of any stabilizers, SS-based NPs (SSC@NPs) can resist the adsorption of serum proteins, preventing the formation of particle agglomerates. Following freeze-drying without addition of cryoprotectants, SSC@NPs powder can be easily resuspended into NP dispersion with a nearly monodispersed distribution. Additionally, SSC@NPs do not result in acute toxicity in mice at a dose of 400 mg/kg with a slow injection. Moreover, doxorubicin (DOX)-loaded SSC@NPs (DOX-SSC@NPs) diminish the biodistribution of DOX in the heart, mitigating DOX-induced cardiotoxicity of mice without compromising therapeutic efficacy. Our results suggest that the self-stabilized SSC@NPs could be a secure and effective drug carrier for intravenous administration when deprived of protective agents. STATEMENT OF SIGNIFICANCE: During manufacturing process such as freeze-drying, or interaction with complex fluids like blood, NPs for systemic drug delivery need to be highly dispersible and structurally intact. In this work, we have demonstrated the self-stability of SSC@NPs subjected to biological media and freeze-drying. This study represents the first work showing water-soluble SS could both act as a dispersion stabilizer and a cryoprotectant due to its hydrophilicity. Plus, good in vivo biocompatibility of SSC@NPs has been confirmed. Therefore, it may be promising that water-soluble SS can be generally used as a safe biomaterial against serum adsorption.


Assuntos
Doxorrubicina , Teste de Materiais , Nanopartículas , Neoplasias Experimentais , Sericinas , Animais , Cardiotoxicidade/prevenção & controle , Doxorrubicina/efeitos adversos , Doxorrubicina/química , Doxorrubicina/farmacocinética , Doxorrubicina/farmacologia , Células Hep G2 , Humanos , Camundongos , Camundongos Endogâmicos BALB C , Nanopartículas/efeitos adversos , Nanopartículas/química , Nanopartículas/uso terapêutico , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/metabolismo , Neoplasias Experimentais/patologia , Coelhos , Sericinas/efeitos adversos , Sericinas/química , Sericinas/farmacocinética , Sericinas/farmacologia , Ensaios Antitumorais Modelo de Xenoenxerto
4.
Macromol Biosci ; 17(12)2017 12.
Artigo em Inglês | MEDLINE | ID: mdl-29045024

RESUMO

The biosafety of sericin remains controversial. The misunderstanding regarding sericin causing adverse biological responses have been clarified by extensively reviewing relevant literatures and experimentally demonstrating that sericin exhibits mild inflammatory responses, negligible allergenicity, and low immunogenicity in vivo. This study supports that sericin is biosafe as a natural biomaterial.


Assuntos
Materiais Biocompatíveis/efeitos adversos , Sericinas/imunologia , Sericinas/farmacologia , Imunidade Adaptativa/efeitos dos fármacos , Animais , Bombyx/genética , Hipersensibilidade a Drogas/etiologia , Fibroínas/imunologia , Fibroínas/farmacologia , Imunidade Inata/efeitos dos fármacos , Inflamação/induzido quimicamente , Masculino , Teste de Materiais , Camundongos , Camundongos Endogâmicos BALB C , Mutação , Células RAW 264.7 , Sericinas/efeitos adversos
5.
J Biomater Sci Polym Ed ; 28(13): 1286-1302, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28420291

RESUMO

In this study, three kinds of antiseptics which were 0.05% chlorhexidine, 0.2% polyhexamethylene biguanide (PHMB), or 200 ppm silver nanoparticle was introduced to incorporate in the sericin-based scaffold to produce the antimicrobial dressing for the treatment of infected chronic wound. The effects of antiseptic incorporation on the stability, release of sericin, and short-term and long-term (6 months) antimicrobial activity of the sericin dressing against gram-negative and gram-positive bacteria were investigated. We showed that the incorporation of each antiseptic did not have significant effect on the internal morphology (pore size ~ 73-105 µm), elasticity (Young's modulus ~ 200-500 kPa), and the sericin release behavior of the sericin-based dressing. The release of sericin from the dressing was prolonged over 120 h and thereafter. Comparing among three antiseptics, 0.05% chlorhexidine incorporated in the sericin dressing showed the highest immediate and long-term (6 months) antimicrobial effect (largest inhibition zone) against most bacteria either gram-positive or gram-negative bacteria. The in vivo safety test following ISO10993 standard (Biological evaluation of medical devices - Part 6: Tests for local effects after implantation) confirmed that the sericin dressing incorporating 0.05% chlorhexidine did not irritate to tissue, comparing with the commercial material used generally in clinic (Allevyn®, Smith & Nephew). We suggested the sericin dressing incorporating 0.05% chlorhexidine for the treatment of infected chronic wound. Chlorhexidine would reduce the risk of infection while the sericin may promote wound healing.


Assuntos
Bandagens , Biguanidas/química , Clorexidina/química , Nanopartículas Metálicas/química , Sericinas/farmacologia , Prata/química , Cicatrização/efeitos dos fármacos , Animais , Antibacterianos/efeitos adversos , Antibacterianos/química , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Bandagens/microbiologia , Portadores de Fármacos/química , Estabilidade de Medicamentos , Masculino , Ratos , Ratos Sprague-Dawley , Segurança , Sericinas/efeitos adversos , Sericinas/química
6.
J Biosci Bioeng ; 112(3): 279-88, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21697006

RESUMO

Sericin, a silk protein, has high potential for use in biomedical applications. In this study, wound dressing membranes of Sericin (S) and Collagen (C) were prepared by glutaraldehyde cross-linking at S/C; 2:1, 1:1, 1:2, and 0:1 weight ratios. They were stable in water for 4 weeks. However, increasing the proportion of sericin had decreasing effect on the membrane stability. Water swelling property of membranes was enhanced with sericin. The highest water swelling was obtained in 1:1 group (9.06 g/g), but increasing collagen or sericin content in the membranes had a diminishing effect. Highest water vapor transmission rate was obtained with 1:2 group (1013.80 g/m(2)/day). Oxygen permeability results showed that 1:2 (7.67 mg/L) and 2:1 (7.85 mg/L) S/C groups were better than the other groups. While sericin decreased the tensile strength and elongation of membranes, it increased modulus. Sericin also increased brittleness of membranes, but their UTS range (24.93-44.92 MPa) was still suitable for a wound dressing. Membranes were not penetrable to microorganisms. Cytotoxicity studies showed that fibroblasts and keratinocytes attached and gained their characteristic morphologies. They also proliferated on membranes significantly. After 1 week of subcutaneous implantation, a fibrous capsule formed around all membranes with an acute inflammation. Sericin containing membranes showed signs of degradation (at 2nd week), while collagen only membranes remained largely intact. Eventually, sericin containing membranes degraded in 3 weeks with moderate inflammatory response. Overall results suggest that sericin/collagen membranes would be favorable as wound dressing material when sericin ratio is less than or equal to the collagen component.


Assuntos
Curativos Biológicos/efeitos adversos , Colágeno/efeitos adversos , Sericinas/efeitos adversos , Cicatrização , Animais , Colágeno/química , Fibroblastos , Glutaral/química , Humanos , Fenômenos Mecânicos , Estudos Prospectivos , Ratos , Ratos Wistar , Sericinas/química , Pele/citologia , Resistência à Tração
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...